Pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas

'aid':40 'angioedema':22 'anti':56 'anti-infect':55 'autoimmun':10 'b':78 'b-cell':77 'bowel':24 'cancer':64,66 'cardiovascular':12 'cell':75,79 'connect':27 'diseas':13,25,29,33 'disord':15 'ebola':42 'hereditari':21 'immun':69 'immunolog':9 'infect':57 'infecti':6 'inflammatori':8,23,26,31 'influenza':39 'leukemia':80 'lymphoma':82 'name':65 'nile':46 'pharmaceut':1,16,34,48,58,59 'reject':54 'sar':41 'skin':32 'system':70 't-cell':73 'tissu':28 'transplant':53 'treatment':4,19,37,51,62 'viral':7 'virus':47 'west':45 'zika':43

BIOCRYST

Owners

Goods & Services